http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1541634-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b0f5fa6606feb99cbc8561777ca3299
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2389-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L89-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L89-06
filingDate 2001-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ed6adc611001f57ee564655e363c31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d518d285775ef3403641bdac8658b67
publicationDate 2005-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1541634-A1
titleOfInvention Process for the preparation of micronised collagen, and its therapeutic applications
abstract Non-denatured triple-helix collagen extracted from animal tendons and skin is purifiednand brought into the form of a stable, sterile and meterable powder having anparticle size of not more than 20 microns. n The powdered collagen so obtained has favourable characteristics of distributionnand asepsis and is particularly efficacious in the more delicate phases of thenwound-healing process compared with powdered collagens obtained by knownnmethods.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013108870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103906794-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013066812-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051439-B2
priorityDate 2000-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0827035-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127843891
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID269023

Total number of triples: 42.